loadpatents
Patent applications and USPTO patent grants for Lancaster; Thomas M..The latest application filed is for "ultra-long acting insulin-fc fusion protein".
Patent | Date |
---|---|
Insulin-Fc fusions and methods of use Grant 11,359,001 - Lancaster , et al. June 14, 2 | 2022-06-14 |
Ultra-long acting insulin-Fc fusion proteins Grant 11,352,407 - Lancaster , et al. June 7, 2 | 2022-06-07 |
Ultra-long Acting Insulin-fc Fusion Protein App 20220098266 - Zion; Todd C. ;   et al. | 2022-03-31 |
Antigen Specific Immunotherapy For Covid-19 Fusion Proteins And Methods Of Use App 20220088182 - Zion; Todd C. ;   et al. | 2022-03-24 |
Ultra-long acting insulin-Fc fusion proteins and methods of use Grant 11,267,862 - Lancaster , et al. March 8, 2 | 2022-03-08 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20220064251 - Lancaster; Thomas M. ;   et al. | 2022-03-03 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20220064250 - Lancaster; Thomas M. ;   et al. | 2022-03-03 |
Ultra-long Acting Insulin-fc Fusion Protein And Methods Of Use App 20220056098 - Lancaster; Thomas M. ;   et al. | 2022-02-24 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20220017590 - Lancaster; Thomas M. ;   et al. | 2022-01-20 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20220009990 - Lancaster; Thomas M. ;   et al. | 2022-01-13 |
Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use Grant 11,213,581 - Zion , et al. January 4, 2 | 2022-01-04 |
Ultra-long acting insulin-Fc fusion protein and methods of use Grant 11,198,719 - Zion , et al. December 14, 2 | 2021-12-14 |
Ultra-long acting insulin-Fc fusion protein and methods of use Grant 11,192,930 - Lancaster , et al. December 7, 2 | 2021-12-07 |
Ultra-long acting insulin-Fc fusion proteins and methods of use Grant 11,186,623 - Lancaster , et al. November 30, 2 | 2021-11-30 |
Antigen Specific Immunotherapy For Covid-19 Fusion Proteins And Methods Of Use App 20210346490 - Zion; Todd C. ;   et al. | 2021-11-11 |
Ultra-long Acting Insulin-fc Fusion Protein And Methods Of Use App 20210340212 - Zion; Todd C. ;   et al. | 2021-11-04 |
Ultra-long Acting Insulin-fc Fusion Protein And Methods Of Use App 20210324033 - Lancaster; Thomas M. ;   et al. | 2021-10-21 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20210309709 - Lancaster; Thomas M. ;   et al. | 2021-10-07 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20210300983 - Lancaster; Thomas M. ;   et al. | 2021-09-30 |
Conjugate Based Systems For Controlled Insulin Delivery App 20210177981 - Yan; Lin ;   et al. | 2021-06-17 |
Ultra-long acting insulin-Fc fusion proteins and methods of use Grant 10,961,294 - Lancaster , et al. March 30, 2 | 2021-03-30 |
Ultra-long acting insulin-Fc fusion proteins and methods of use Grant 10,947,292 - Lancaster , et al. March 16, 2 | 2021-03-16 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20200407413 - LANCASTER; THOMAS M. ;   et al. | 2020-12-31 |
Ultra-long acting insulin-FC fusion proteins and methods of use Grant 10,870,686 - Lancaster , et al. December 22, 2 | 2020-12-22 |
Ultra-long acting insulin-Fc fusion proteins and methods of use Grant 10,851,147 - Lancaster , et al. December 1, 2 | 2020-12-01 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20200231646 - Lancaster; Thomas M. ;   et al. | 2020-07-23 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20200157170 - Lancaster; Thomas M. ;   et al. | 2020-05-21 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20200157171 - Lancaster; Thomas M. ;   et al. | 2020-05-21 |
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use App 20200157169 - Lancaster; Thomas M. ;   et al. | 2020-05-21 |
Insulin-fc Fusions And Methods Of Use App 20200131243 - Lancaster; Thomas M. ;   et al. | 2020-04-30 |
Insulin-Fc fusions and methods of use Grant 10,597,435 - Lancaster , et al. | 2020-03-24 |
Insulin-fc Fusions And Methods Of Use App 20190315828 - Lancaster; Thomas M. ;   et al. | 2019-10-17 |
Conjugate based systems for controlled drug delivery Grant 10,398,781 - Zion , et al. Sep | 2019-09-03 |
Conjugate Based Systems For Controlled Drug Delivery App 20180064824 - Zion; Todd C. ;   et al. | 2018-03-08 |
Binding-site modified lectins and uses thereof Grant 9,745,355 - Zion , et al. August 29, 2 | 2017-08-29 |
Conjugate based systems for controlled drug delivery Grant 9,579,391 - Zion , et al. February 28, 2 | 2017-02-28 |
Crystalline Insulin-conjugates App 20170022262 - Lancaster; Thomas M. ;   et al. | 2017-01-26 |
Crystalline insulin-conjugates Grant 9,463,249 - Lancaster , et al. October 11, 2 | 2016-10-11 |
Conjugate Based Systems For Controlled Drug Delivery App 20160193351 - Zion; Todd C. ;   et al. | 2016-07-07 |
Conjugate based systems for controlled drug delivery Grant 9,265,838 - Zion , et al. February 23, 2 | 2016-02-23 |
Conjugate Based Systems For Controlled Drug Delivery App 20150265717 - Zion; Todd C. ;   et al. | 2015-09-24 |
Exogenously triggered controlled release materials and uses thereof Grant 9,114,176 - Zion , et al. August 25, 2 | 2015-08-25 |
Terminally-functionalized conjugates and uses thereof Grant 9,095,623 - Zion , et al. August 4, 2 | 2015-08-04 |
Recombinantly expressed insulin polypeptides and uses thereof Grant 9,074,015 - Lancaster , et al. July 7, 2 | 2015-07-07 |
Recombinant lectins, binding-site modified lectins and uses thereof Grant 9,068,013 - Lancaster , et al. June 30, 2 | 2015-06-30 |
Conjugate based systems for controlled drug delivery Grant 9,050,370 - Zion , et al. June 9, 2 | 2015-06-09 |
Synthetic conjugates and uses thereof Grant 8,940,690 - Zion , et al. January 27, 2 | 2015-01-27 |
Drug-ligand conjugates, synthesis thereof, and intermediates thereto Grant 8,933,207 - Chen , et al. January 13, 2 | 2015-01-13 |
Crystalline insulin-conjugates Grant 8,906,850 - Zion , et al. December 9, 2 | 2014-12-09 |
Binding-site Modified Lectins And Uses Thereof App 20140342980 - Zion; Todd C. ;   et al. | 2014-11-20 |
Exogenously triggered controlled release materials and uses thereof Grant 8,846,103 - Zion , et al. September 30, 2 | 2014-09-30 |
Conjugate Based Systems For Controlled Drug Delivery App 20140274888 - Zion; Todd C. ;   et al. | 2014-09-18 |
Crystalline Insulin-conjugates App 20140275476 - Lancaster; Thomas M. ;   et al. | 2014-09-18 |
Exogenously Triggered Controlled Release Materials And Uses Thereof App 20140256622 - Zion; Todd C. ;   et al. | 2014-09-11 |
Methods for reducing the mitogenicity of lectin compositions Grant 8,729,242 - Lancaster , et al. May 20, 2 | 2014-05-20 |
Terminally Functionalized Conjugates And Uses Thereof App 20140121159 - Zion; Todd C. ;   et al. | 2014-05-01 |
Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator Grant 8,697,643 - Lancaster , et al. April 15, 2 | 2014-04-15 |
Soluble Non-depot Insulin Conjugates And Uses Thereof App 20140037699 - Zion; Todd C. ;   et al. | 2014-02-06 |
Terminally-functionalized conjugates and uses thereof Grant 8,623,345 - Zion , et al. January 7, 2 | 2014-01-07 |
Polynucleotide aptamer-based cross-linked materials and uses thereof Grant 8,603,529 - Zion , et al. December 10, 2 | 2013-12-10 |
Recombinant Lectins, Binding-site Modified Lectins And Uses Thereof App 20130324702 - Lancaster; Thomas M. ;   et al. | 2013-12-05 |
Uses Of Macrophage Mannose Receptor To Screen Compounds And Uses Of These Compounds App 20130302825 - Murikipudi; Sylaja ;   et al. | 2013-11-14 |
Soluble non-depot insulin conjugates and uses thereof Grant 8,569,231 - Zion , et al. October 29, 2 | 2013-10-29 |
Drug-ligand Conjugates, Synthesis Thereof, And Intermediates Thereto App 20130190475 - Chen; Zhiyu ;   et al. | 2013-07-25 |
Recombinantly Expressed Insulin Polypeptides And Uses Thereof App 20130190476 - Lancaster; Thomas M. ;   et al. | 2013-07-25 |
Drug-ligand Conjugates, Synthesis Thereof, And Intermediates Thereto App 20130131310 - Kane; John ;   et al. | 2013-05-23 |
Polymer-drug Conjugates App 20120135919 - Lancaster; Thomas M. ;   et al. | 2012-05-31 |
Exogenously Triggered Controlled Release Materials And Uses Thereof App 20120046223 - Zion; Todd C. ;   et al. | 2012-02-23 |
Terminally-functionalized Conjugates And Uses Thereof App 20120014908 - Zion; Todd C. ;   et al. | 2012-01-19 |
Soluble Non-depot Insulin Conjugates And Uses Thereof App 20120010134 - Zion; Todd C. ;   et al. | 2012-01-12 |
Conjugate Based Systems For Controlled Drug Delivery App 20110301083 - Zion; Todd C. ;   et al. | 2011-12-08 |
Polynucleotide Aptamer-based Cross-linked Materials And Uses Thereof App 20110281939 - Zion; Todd C. ;   et al. | 2011-11-17 |
Crystalline Insulin-conjugates App 20110281791 - Zion; Todd C. ;   et al. | 2011-11-17 |
Binding-site Modified Lectins And Uses Thereof App 20110281792 - Zion; Todd C. ;   et al. | 2011-11-17 |
Synthetic Conjugates And Uses Thereof App 20110275560 - Zion; Todd C. ;   et al. | 2011-11-10 |
Methods For Reducing The Mitogenicity Of Lectin Compositions App 20100130726 - LANCASTER; Thomas M. ;   et al. | 2010-05-27 |
Methods for reducing the mitogenicity of lectin compositions Grant 7,687,608 - Lancaster , et al. March 30, 2 | 2010-03-30 |
Methods for reducing the mitogenicity of lectin compositions App 20070110811 - Lancaster; Thomas M. ;   et al. | 2007-05-17 |
Polymer-drug conjugates App 20070099820 - Lancaster; Thomas M. ;   et al. | 2007-05-03 |
Porous carbon structures and methods App 20050214539 - Ying, Jackie Y. ;   et al. | 2005-09-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.